SCICLONE PHARMACEUTICALS INC Assets, Fair Value Disclosure
SCICLONE PHARMACEUTICALS INC had Assets, Fair Value Disclosure of $20.46 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2017-08-09
- 2017-06-30: Assets, Fair Value Disclosure $20.46M.
- 2017-03-31: Assets, Fair Value Disclosure $20.67M.
- 2016-12-31: Assets, Fair Value Disclosure $20.50M.
- 2016-09-30: Assets, Fair Value Disclosure $22.41M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2017-06-30 | $20.46M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $20.67M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $20.50M 10-Q · filed 2017-08-09 |
| 2016-09-30 | $22.41M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $19.69M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $19.68M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $19.68M 10-K · filed 2017-03-09 |
| 2015-09-30 | $19.68M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $19.75M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $19.75M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $19.75M 10-K · filed 2016-03-11 |
| 2014-09-30 | $19.75M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $19.75M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $19.75M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $28.34M 10-K · filed 2015-03-12 |
| 2013-09-30 | $35.58M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $45.96M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $50.95M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $43.96M 10-K · filed 2014-03-17 |
| 2012-09-30 | $53.88M 10-Q/A · filed 2013-04-01 |
| 2012-06-30 | $29.87M 10-Q/A · filed 2013-04-01 |
| 2011-12-31 | $32.21M 10-Q/A · filed 2013-04-01 |